Plasmonic biosensors enable development of new easy-to-use health tests
Researchers have developed a biosensor that can detect diseased exosomes, important indicators of various health conditions...
List view / Grid view
Researchers have developed a biosensor that can detect diseased exosomes, important indicators of various health conditions...
As part of EPR’s Women in Pharma series, Andrea Miller, Head of Global R&D and Regulatory Affairs for Mylan, talks to Science Editor Dr Zara Kassam about the importance of being 'team smart', being open to new ideas and listening to other people’s perspectives and learning from them...
Researchers believe they have a way to create the structural framework for growing living tissue using an off-the-shelf 3-D printer...
Drug molecule in tapeworm medicine activates protein implicated in the development of Parkinson's disease...
Light-emitting nanoprobes can detect cancer early and track the spread of tiny tumours...
The FDA has approved Admelog, a short-acting insulin indicated to improve control in blood sugar levels in diabetes...
Researchers have shown that giving a stronger single-dose of a live oral vaccine could be an effective tool in controlling outbreaks of cholera...
A drug used to treat rheumatoid arthritis improves survival after hematopoietic stem cell transplant...
FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option for moderate-to-severe opioid use disorder...
New research in rats suggests the possibility of bioengineering artificial ovaries in the lab to provide a safer, more natural hormone replacement therapy for women...
AstraZeneca has announced positive top-line results of the Phase IV ASCENT trial for Tudorza Pressair in patients with moderate to very severe COPD...
A single dose of lithium chloride can block sleep disturbances, memory loss, and learning problems tied to foetal alcohol syndrome...
A new drug delivery system could provide a smart technology for the targeted treatment of a variety of serious diseases...
The FDA has approved Ogivri as a biosimilar to Herceptin for the treatment of patients with breast or metastatic stomach cancer whose tumours overexpress the HER2 gene...
Children with an extremely deadly form of brain cancer may benefit from a new treatment that aims to direct an immune response against an abnormally shaped protein found on cancer cells...